申请人:Gruppo Lepetit S.p.A.
公开号:US04783461A1
公开(公告)日:1988-11-08
The present invention is directed to new 3,6-disubstituted-1,2,4-triazolo[3,4-a]phthalazine derivatives of formula I ##STR1## wherein R represents phenyl or substituted phenyl, n is 1 or 2, R.sup.1 is an amino group of formula NR.sup.4 R.sup.5, or an alkoxy of cycloalkoxy group of formula OR.sup.6, and R.sup.2 and R.sup.3 represent hydrogen, halogen, (C.sub.1 -C.sub.4)alkyl or (C.sub.1 -C.sub.4)alkoxy, to the process for their preparation and to the pharmaceutical compositions containing them. The compounds of the present invention are as active as anti-anxiety substances.
本发明涉及一种新的3,6-二取代-1,2,4-三唑并[3,4-a]菲嗪衍生物,其化学式为I,其中R代表苯基或取代苯基,n为1或2,R.sup.1为公式NR.sup.4R.sup.5的氨基或公式OR.sup.6的烷氧基或环烷氧基,R.sup.2和R.sup.3代表氢、卤素、(C.sub.1-C.sub.4)烷基或(C.sub.1-C.sub.4)烷氧基,本发明还涉及制备它们的方法以及含有它们的药物组合物。本发明化合物与抗焦虑物质具有相同的活性。